期刊文献+

序贯疗法与7d三联疗法治疗幽门螺杆菌的疗效比较

Comparative Study Between Sequential Therapy and 7-day Triple Therapy in Helicobacter Pylori Infection Treatment
下载PDF
导出
摘要 目的:比较序贯疗法与7d三联疗法治疗幽门螺杆菌的疗效。方法:92例HP阳性病例,随机分为两组:治疗组:42例前5d予质子泵抑制剂(proton pump inhibitor,PPI)和阿莫西林,后5d予PPI、克拉霉素和替硝唑。对照组:50例予PPI、阿莫西林和克拉霉素,疗程7d。结果:序贯疗法HP根除率为97.62%,7d三联疗法HP根除率为36%。结论:序贯疗法与7d三联疗法对本地区的根除率有显著差异。 Objective:To assess the efficacy of sequential regimen compared with conventional 7-day triple therapies.Methods:92 Helicobacter pylori(H.pylori) infected patients were enrolled.All patients were randomized either to receive 10-day sequential therapy Group(42cases),proton pump inhibitor(PPI) plus amoxicillin for the first 5 days,followed by PPI,clarithromycin and tinidazole twice daily for the remaining 5 days or to standard 7-day therapy Group(50cases),PPI,clarithromycin and amoxicillin twice daily.Results:H.pylori eradication was achieved in 41(97.62%) of 42 individuals in Sequential regimen,18(36%) of 50 in 7-day triple therapies.Conclusion:The sequential regimen is significantly more effective than 7-day triple therapies in this area.
出处 《医学理论与实践》 2011年第22期2663-2664,共2页 The Journal of Medical Theory and Practice
关键词 序贯疗法 三联疗法 幽门螺杆菌 根除 Sequential regimen Triple regimen Helicobacter pylori Eradication
  • 相关文献

参考文献5

二级参考文献27

  • 1成虹,胡伏莲.北京地区幽门螺杆菌耐药情况及其变化趋势[J].中华医学杂志,2005,85(39):2754-2757. 被引量:176
  • 2Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht Ⅲ Consensus Report. Gut, 2007, 56 (6): 772-781.
  • 3Laheij R J, Rossum LG, Jansen JB, et al. Evaluation of treatment regimens to cure Helicobacter pylori infection -- a meta-analysis. Aliment Pharmcol Ther, 1999, 13 (7): 857-864.
  • 4Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther, 2003, 17 (5): 719-726.
  • 5Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med, 2007, 146 (8): 556-563.
  • 6Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2000, 14 (6): 715- 718.
  • 7De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis, 2001, 33 (8): 676-679.
  • 8Calvet X, Garcia N, Lopez T, et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther, 2000, 14 (5): 603-609.
  • 9Hassan C, De Francesco V, Zullo A, et al. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmaeotherapy. Aliment Pharmacol Ther, 2003, 18 (6): 641-646.
  • 10Gomollon F, Santolaria S, Sicilia B, et al. Helicobacter pylori resistance to metronidazole and clarythromicin: descriptive analysis 1997-2000. Med Clin (Barc), 2004, 123 (13): 481-485.

共引文献471

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部